Wells Fargo raised the firm’s price target on Omega Healthcare (OHI) to $48 from $45 and keeps an Overweight rating on the shares. The firm says that despite a few high-profile exceptions, most REITs delivered Q3 2025 earnings and outlooks reflecting healthy operating conditions despite macro and labor market concerns.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega, Alphabet, Honeywell, Freeport, DoorDash: Trending by Analysts
- Omega Healthcare initiated with a Buy at UBS
- Omega Healthcare: Strong Buy Rating Driven by Strategic Investments and Positive Market Trends
- Omega Healthcare price target raised to $48 from $46 at BofA
- Omega Healthcare price target raised to $45 from $42 at Scotiabank